Literature DB >> 520659

The incidence of dipyrone-induced agranulocytosis in Greece during 1975.

D D Varonos, S Santamouris, S Karambali.   

Abstract

A retrospective epidemiological study was conducted in Greece during 1975 to assess the incidence of agranulocytosis following treatment with dipyrone. Twenty-four cases of agranulocytosis were reported, of which fifteen were possibly associated with medication. If all fifteen cases are attributed to dipyrone, the incidence of agranulocytosis following treatment with this drug lies between one case in every 133,000 and one case in every 466,000 treatments.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520659     DOI: 10.1177/030006057900700617

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

Review 1.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Agranulocytosis associated with dipyrone (metamizol).

Authors:  Luisa Ibáñez; Xavier Vidal; Elena Ballarín; Joan-Ramon Laporte
Journal:  Eur J Clin Pharmacol       Date:  2004-12-03       Impact factor: 2.953

4.  The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

Authors:  Hervé Allain; Albert A Ramelet; Elisabeth Polard; Danièle Bentué-Ferrer
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.